Michael W. Nall
President and Chief Executive Officer
Mr. Nall has over 30 years of healthcare leadership experience and has been our President and CEO since 2013. During this time, the company has transitioned from R and D to Commercialization. Mr. Nall has previously served in Commercial and Operational leadership roles in multiple companies including his most recent role as General Manager, North America Sales and Marketing for GE Healthcare’s Clarient division, leading all aspects of commercialization including Sales, Marketing and Reimbursement for Laboratory Services. Prior to Clarient, Mr. Nall served at Impath, Maquet Surgical, Midwest Medical, CVS Specialty Distribution and American Cyanamid.
Mr. Nall also serves on a non-profit board for the Clearity Foundation which is dedicated to providing support for women diagnosed with Ovarian Cancer.
Chief Financial Officer and Senior Vice President of Operations
Tim Kennedy brings more than 30 years of financial and operational leadership experience, including over 25 years in the clinical diagnostics industry. Most recently, Tim served as Chief Financial Officer of Millennium Health, a privately held leading urine drug testing and pharmacogenetics laboratory company. Prior to Millennium, he held various leadership positions at leading companies, such as PLUS Diagnostics, Diagnostic Imaging Management and National Health Laboratories (presently known as LabCorp). Tim holds a bachelor’s degree in Business – Accounting/Information Technology from Keane University.
Michael C. Dugan, M.D.
Senior Vice President, Chief Medical Officer and Medical Director
Dr. Dugan leads our clinical strategic development as CMO and oversees our CAP accredited CLIA clinical laboratory as Medical Director. He is an experienced physician and biotech executive who has directed several major commercial reference laboratories and helped launch numerous novel molecular diagnostic assays and platforms used in oncology, infectious disease and public health applications such as cancer screening, monitoring, diagnosis and therapy selection. Dr. Dugan has held leadership positions with Clinical Genomics, Exact Sciences, Genzyme Genetics (acquired by LabCorp), Quest Diagnostics (including acquired companies AmeriPath and Specialty Laboratories), and UCLA.
A graduate of the University of Notre Dame (B.S. Biology) and University of Arizona College of Medicine (M.D.), he completed his post-graduate medical education in anatomic pathology at Yale-New Haven Hospital and continued training in pathology and laboratory medicine at Children’s Hospital Los Angeles and UCLA. He is board-certified in Anatomic and Clinical Pathology.
Senior Vice President, Corporate Development
Mike Terry is a seasoned veteran in the molecular diagnostics and liquid biopsy industries, Mike has vast leadership experience managing large and small commercial teams. Prior to Biocept, he served as Executive Vice President of Sequenom, Inc., and more recently Trovagene, Inc. He also has held leadership positions at GE Healthcare’s Marquette Medical division, Lumenis Ltd, Aspect Medical Systems Inc. and Ligand Diagnostics.
Michael W. Brown
General Counsel, Compliance and Privacy Officer
Michael Brown has more than 20 years of experience in providing legal, compliance and privacy advice to healthcare companies, with the last 9 years focused in the oncology laboratory area. Michael has served as senior counsel in various companies such as GE Healthcare Company, Edwards Lifescience (medical device), Tenet HealthSystems (hospitals), InSight Health Services Corp. (diagnostic imaging) and Apria Healthcare (home respiratory and infusion). In addition, Michael has been created and implemented multiple compliance and privacy programs, both national and international, and resolving governmental investigations with the Office of Inspector General, Office of Civil Rights and other governmental entities. He is a national speaker on healthcare, compliance, privacy and corruption and served on the Medical Device and Diagnostic Compliance Committee for AdvaMed revising the Code of Ethics for the medical device industry. Michael received his law degree from Pepperdine University School of Law and a Bachelor of Arts degree (cum laude) in Political Science from California State University at Fullerton.
Senior Director, Quality
Tom Nauman is a 30-year professional in the bio-tech field including 25 years in Quality Assurance and eight years in positions as Director of Quality. He has worked for such companies as Genoptics / Novartis, Accriva / Instrumentation Laboratory, Abbott Laboratories, Becton Dickinson, and Covidien / Medtronic. Tom received a Bachelor of Science degree in Industrial Engineering from Iowa State University.
Vice President, Sales
Antonio Paternostro brings over 15 years of Sales leadership experience in the clinical diagnostics, anatomic pathology, and biotechnology industries. Antonio served multiple commercial leadership positions at PLUS DX, Miraca Life Sciences and most recently GenomeDx Biosciences (now Decipher Biosciences). Antonio holds a Bachelor of Science degree in Biology and Secondary Education from Central Connecticut State University.
Senior Director, Product Development
Tim Schofield has over twenty years of sales and marketing experience working in pharmaceuticals, clinical diagnostics and life sciences. He started his career with Johnson & Johnson and has held commercial leadership roles at Prometheus Laboratories, NanoString and Nucleus Biologics. Tim received his Bachelor of Arts in Business Administration from Western Washington University and an MBA from Willamette University.
Senior Director, People and Culture / Facilities
Gary Marchetti brings more than 30 years of human resources and business management leadership experience to Biocept. Most recently, Gary served as a Senior HR Business Partner at Genentech. He also brings to Biocept diverse HR experience, including Manager of Organization Learning and Development at Starwood Hotel and Resorts, HR Manager with The Walt Disney Company, Director of Technical Services at Perimeter Church, and CEO of Gamy and Ary, Inc. a boutique construction firm. Gary holds an MS in Organizational Behavior and BS in Business Administration, Management, and Operations from Golden Gate University.